טוען...
Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
Biomarker-guided treatment is a rapidly developing area of medicine, where treatment choice is personalised according to one or more of an individual’s biomarker measurements. A number of biomarker-guided trial designs have been proposed in the past decade, including both adaptive and non-adaptive t...
שמור ב:
| הוצא לאור ב: | J Pers Med |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5374391/ https://ncbi.nlm.nih.gov/pubmed/28125057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm7010001 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|